8-53993705-T-C
Variant summary
Our verdict is Likely benign. Variant got -2 ACMG points: 2P and 4B. PM2BP4_Strong
The ENST00000521604.7(TCEA1):āc.283A>Gā(p.Ile95Val) variant causes a missense change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.000164 in 1,613,904 control chromosomes in the GnomAD database, with no homozygous occurrence. In-silico tool predicts a benign outcome for this variant. 15/20 in silico tools predict a benign outcome for this variant. Variant has been reported in ClinVar as Uncertain significance (ā ).
Frequency
Consequence
ENST00000521604.7 missense
Scores
Clinical Significance
Conservation
Genome browser will be placed here
ACMG classification
Verdict is Likely_benign. Variant got -2 ACMG points.
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | Protein | UniProt |
---|---|---|---|---|---|---|---|---|
TCEA1 | NM_006756.4 | c.283A>G | p.Ile95Val | missense_variant | 4/10 | ENST00000521604.7 | NP_006747.1 |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Protein | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|---|
TCEA1 | ENST00000521604.7 | c.283A>G | p.Ile95Val | missense_variant | 4/10 | 1 | NM_006756.4 | ENSP00000428426.2 |
Frequencies
GnomAD3 genomes AF: 0.000145 AC: 22AN: 152232Hom.: 0 Cov.: 32
GnomAD3 exomes AF: 0.0000803 AC: 20AN: 249020Hom.: 0 AF XY: 0.0000592 AC XY: 8AN XY: 135102
GnomAD4 exome AF: 0.000166 AC: 243AN: 1461554Hom.: 0 Cov.: 30 AF XY: 0.000168 AC XY: 122AN XY: 727062
GnomAD4 genome AF: 0.000144 AC: 22AN: 152350Hom.: 0 Cov.: 32 AF XY: 0.000107 AC XY: 8AN XY: 74498
ClinVar
Submissions by phenotype
not specified Uncertain:1
Uncertain significance, criteria provided, single submitter | clinical testing | Ambry Genetics | Mar 25, 2022 | The c.283A>G (p.I95V) alteration is located in exon 4 (coding exon 4) of the TCEA1 gene. This alteration results from a A to G substitution at nucleotide position 283, causing the isoleucine (I) at amino acid position 95 to be replaced by a valine (V). Based on insufficient or conflicting evidence, the clinical significance of this alteration remains unclear. - |
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at